Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Review Article

Nanocarrier-based Drug Delivery System for Cancer Therapeutics: A Review of the Last Decade

Author(s): Muhammad Sohail, Wenna Guo, Zhiyong Li, Hui Xu*, Feng Zhao, Daquan Chen and Fenghua Fu

Volume 28 , Issue 19 , 2021

Published on: 05 October, 2020

Page: [3753 - 3772] Pages: 20

DOI: 10.2174/0929867327666201005111722

Price: $65

Abstract

In recent years, due to the shortcomings of conventional chemotherapy, such as poor bioavailability, low treatment index, and unclear side effects, the focus of cancer research has shifted to new nanocarriers of chemotherapeutic drugs. By using biodegradable materials, nanocarriers generally have the advantages of good biocompatibility, low side effects, targeting, controlled release profile, and improved efficacy. More to the point, nanocarrier based anti-cancer drug delivery systems clearly show the potential to overcome the problems associated with conventional chemotherapy. In order to promote the in-depth research and development in this field, we herein summarized and analyzed various nanocarrier based drug delivery systems for cancer therapy, including the concepts, types, characteristics, and preparation methods. The active and passive targeting mechanisms of cancer therapy were also included, along with a brief introduction of the research progress of nanocarriers used for anti-cancer drug delivery in the past decade.

Keywords: Nanocarriers, cancer chemotherapy, drug delivery system, targeting mechanisms, theranostic, application.


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy